AFG
AVEO

Albion Financial Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Albion Financial Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,380
Closed -$20K – 223
2019
Q3 		$20K Hold
2,380
– – ﹤0.01% 203
2019
Q2 		$16K Hold
2,380
– – ﹤0.01% 206
2019
Q1 		$20K Hold
2,380
– – ﹤0.01% 201
2018
Q4 		$38K Buy
+2,380
New +$52.4K 0.01% 193

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Albion Financial Group's AVEO Position: Q4 2019 in Review

Albion Financial Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2019, closing a stake of 2,380 shares — an estimated $20K sold.

Albion Financial Group first reported a position in AVEO in Q4 2018 and held it in 4 quarters. The position peaked at $38K in Q4 2018. 61 funds tracked by Wall St. Rank hold AVEO as of Q4 2019.

  • Albion Financial Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • Albion Financial Group sold 2,380 AVEO Pharmaceuticals, Inc. shares in Q4 2019, an estimated $20K.
  • Albion Financial Group first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2018 and held it in 4 quarters.
  • Albion Financial Group's AVEO Pharmaceuticals, Inc. position peaked at $38K in Q4 2018.
  • 61 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2019.

Based on Albion Financial Group's 13F filing for Q4 2019, filed 31 Jan 2020.